Risk of venous thromboembolism in COVID-19 infection

Meeri Honkanen; Simo Sirkeoja; Hanna Viskari; Ville Kailankangas; Marjatta Sinisalo; Jaana Syrjänen

doi:10.1111/imj.16145

Risk of venous thromboembolism in COVID-19 infection

Meeri Honkanen, Simo Sirkeoja, Hanna Viskari, Ville Kailankangas, Marjatta Sinisalo, Jaana Syrjänen

SIST, Internal medicine

Research output: Contribution to journal › Article › Scientific › peer-review

3 Citations (Scopus)

22 Downloads (Pure)

Abstract

The incidence of venous thromboembolism (VTE) for non-hospitalised patients with coronavirus disease-2019 infection has not been very widely studied. 13 019 persons with a positive SARS-CoV-2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study population, 293 (66%) of these were pulmonary embolisms. A positive SARS-CoV-2 test did not increase the risk for VTE in the univariate analysis (odds ratio (OR): 1.0, 95% confidence interval (CI): 0.69-1.4) or multivariable analysis (OR: 1.36, 95% CI: 0.93-1.97).

Original language	English
Pages (from-to)	1478-1480
Number of pages	3
Journal	INTERNAL MEDICINE JOURNAL
Volume	53
Issue number	8
DOIs	https://doi.org/10.1111/imj.16145
Publication status	Published - Aug 2023
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 1

Access to Document

10.1111/imj.16145Licence: CC BY-NC

Internal Medicine Journal - 2023 - HonkanenFinal published version, 676 KBLicence: CC BY-NC

https://urn.fi/URN:NBN:fi:tuni-202308177635Licence: CC BY-NC

Cite this

@article{ba7bd44d93d44778845340a0956e849b,

title = "Risk of venous thromboembolism in COVID-19 infection",

abstract = "The incidence of venous thromboembolism (VTE) for non-hospitalised patients with coronavirus disease-2019 infection has not been very widely studied. 13 019 persons with a positive SARS-CoV-2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study population, 293 (66%) of these were pulmonary embolisms. A positive SARS-CoV-2 test did not increase the risk for VTE in the univariate analysis (odds ratio (OR): 1.0, 95% confidence interval (CI): 0.69-1.4) or multivariable analysis (OR: 1.36, 95% CI: 0.93-1.97).",

author = "Meeri Honkanen and Simo Sirkeoja and Hanna Viskari and Ville Kailankangas and Marjatta Sinisalo and Jaana Syrj{\"a}nen",

note = "{\textcopyright} 2023 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.",

year = "2023",

month = aug,

doi = "10.1111/imj.16145",

language = "English",

volume = "53",

pages = "1478--1480",

journal = "INTERNAL MEDICINE JOURNAL",

issn = "1444-0903",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Risk of venous thromboembolism in COVID-19 infection

AU - Honkanen, Meeri

AU - Sirkeoja, Simo

AU - Viskari, Hanna

AU - Kailankangas, Ville

AU - Sinisalo, Marjatta

AU - Syrjänen, Jaana

PY - 2023/8

Y1 - 2023/8

N2 - The incidence of venous thromboembolism (VTE) for non-hospitalised patients with coronavirus disease-2019 infection has not been very widely studied. 13 019 persons with a positive SARS-CoV-2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study population, 293 (66%) of these were pulmonary embolisms. A positive SARS-CoV-2 test did not increase the risk for VTE in the univariate analysis (odds ratio (OR): 1.0, 95% confidence interval (CI): 0.69-1.4) or multivariable analysis (OR: 1.36, 95% CI: 0.93-1.97).

AB - The incidence of venous thromboembolism (VTE) for non-hospitalised patients with coronavirus disease-2019 infection has not been very widely studied. 13 019 persons with a positive SARS-CoV-2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study population, 293 (66%) of these were pulmonary embolisms. A positive SARS-CoV-2 test did not increase the risk for VTE in the univariate analysis (odds ratio (OR): 1.0, 95% confidence interval (CI): 0.69-1.4) or multivariable analysis (OR: 1.36, 95% CI: 0.93-1.97).

U2 - 10.1111/imj.16145

DO - 10.1111/imj.16145

M3 - Article

C2 - 37449583

SN - 1444-0903

VL - 53

SP - 1478

EP - 1480

JO - INTERNAL MEDICINE JOURNAL

JF - INTERNAL MEDICINE JOURNAL

IS - 8

ER -

Risk of venous thromboembolism in COVID-19 infection

Abstract

Publication forum classification

Access to Document

Fingerprint

Cite this